Ethnic differences translate to inadequacy of high-risk screening for gestational diabetes mellitus in an Asian population: a cohort study.
Yap-Seng Chong, Shirong Cai, Harvard Lin...
https://pubmed.ncbi.nlm.nih.gov/25273851/Actively Recruiting
Led by National University Health System, Singapore · Updated on 2025-05-28
800
Participants Needed
1
Research Sites
N/A
Total Duration
Gestational diabetes mellitus GDM is a temporary high blood sugar condition that occurs during pregnancy in women without prior chronic diabetes. This condition increases risks like preterm birth and the development of pre-diabetes or type 2 diabetes after delivery. GDM is especially common among Asian pregnant women, partly due to higher rates of overweight and obesity and genetic factors. This research aims to better understand different types of GDM by studying cardio-metabolic profiles and treatment responses during pregnancy to improve care and outcomes. The study will follow 800 overweight or obese pregnant women of Chinese, Malay, or Indian ethnicity, recruited by 13 weeks and 6 days of pregnancy, who have no history of diabetes. These participants will be monitored from early pregnancy until delivery. The research uses advanced tools like continuous glucose monitoring devices worn for at least 7 days during clinic visits and untargeted metabolite profiling to capture detailed metabolic information. Screening for GDM will occur at 24 to 28 weeks of gestation. Participants will complete questionnaires in English and undergo regular assessments including glucose monitoring and biomarker measurements. The study aims to identify specific GDM profiles and how they respond to treatments such as diet or insulin. Researchers will use these findings to develop better screening, treatment, and follow-up guidelines for women with GDM. The study will last about three years, with ongoing observation through pregnancy and delivery.
CONDITIONS
Studying Phenotypes of Gestational Diabetes Mellitus in an Asian Pregnant Cohort
L
Ling-Jun Li, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National University Health System, Singapore
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - Up to 13 weeks and 6 days of gestation
Participants are screened for eligibility to participate in the trial.
Duration - 4 weeks
Participants are screened for gestational diabetes mellitus (GDM) between 24 and 28 weeks of gestation.
1 visit (in-person)
Duration - From 24-28 weeks of gestation until delivery
Participants are followed with continuous glucose monitoring and cardio-metabolic profiling until delivery to study GDM phenotypes and treatment responses.
Multiple visits during pregnancy including continuous glucose monitoring for at least 7 days
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Yap-Seng Chong, Shirong Cai, Harvard Lin...
https://pubmed.ncbi.nlm.nih.gov/25273851/Camille E Powe, Marie-France Hivert, Miriam S Udler
https://pubmed.ncbi.nlm.nih.gov/32843565/Qi Yu, Izzuddin M Aris, Kok Hian Tan...
https://pubmed.ncbi.nlm.nih.gov/31681170/H David McIntyre, Patrick Catalano, Cuilin Zhang...
https://pubmed.ncbi.nlm.nih.gov/31296866/National University Health System, Singapore
Lead Sponsor